How 3D ‘bio-printing’ can shape mini-organs
9 Jun 2023, 4 p.m.
Scientists from the NIHR Great Ormond Street Hospital Biomedical Research Centre (a collaboration between GOSH and UCL) and University of Padova, Italy, have shown for the first time how 3D printing can be achieved inside ‘mini-organs’ growing in hydrogels - controlling their shape, activity, and even forcing tissue to grow into ‘moulds’.
This can help teams study cells and organs more accurately, create realistic models of organs and disease, and even better understand how cancer spreads through different tissues.
A particularly promising area of research at the Zayed Centre for Research (a partnership between Great Ormond Street Hospital (GOSH), GOSH Charity and University College London Great Ormond Street Institute of Child Health (UCL GOS ICH)) is organoid science – the creation of micro-versions of organs like the stomach, the intestines and the lungs. But this tissue almost always grows in an uncontrolled way and doesn’t represent the complex structure of naturally occurring organs. This is particularly important as an organ’s shape and structure is as crucial as its cellular make up – in the stomach, or lungs and heart, for example.
This new research shows, how scientists can create solid structures within a pre-existing gel to solidify specific patterns in real time, guiding organoids growing in the gel into a particular structure by using light from a high-specification microscope. This means that any cell in the growing mini-organ or entire organoids will grow in a specific and precise way.
The paper, published in Nature Communications, shows how the team hope to recreate and study what happens to an organ’s function when it doesn’t grow correctly – for example in many malformations that develop in the early stages of pregnancy.
The team hope this research will create better models of disease which means that their studies are more reliable, the results are of better quality and the need for animal research is one day reduced. The work could also lead to treatment through the delivery of biologically accurate ‘patches’ in living organs.
It’s been amazing to see these precise structures begin to form before our eyes due to our small but painstaking adjustments in the polymer gel. We’re really excited to see where this can take us in the understanding of human disease and one day, treatment.
This work is an exemplar of the advancements of the multidisciplinary approach that is exploding in biomedical research. The ability to reproduce models of organs in the lab and the development of technologies that help scientist to recapitulate healthy and diseased tissues and organ complexity on the bench is the outset of how translational medicine will change in the next future.
Examples of 'printing' in action
To study microscopic brain cells called neurons, organoid research would traditionally create disordered bundles of neurons that are impossible to isolate and study. This technique allows the team to create hardened gel ‘rails’ for the neurons to grow along, like the lanes of an Olympic pool.
To create microscopic intestines with the same shape as ‘real’ developing intestines, the team created a complex hydrogel mould that guided organoids into shapes that mimic the complex structures of a developing intestine called ‘crypts’ and ‘villi’.
Scientists were able to pattern a hydrogel to encourage lung cells to create branches, like they do in ‘real’ lung.
To study how cancer travels through tissue of different hardness and density, the team created hardened gel cages around cancer cells and monitored how the cancer cells movement changes depending on the density of its surroundings – this is important for understanding the spread of cancer.
This work as an excellent example of how we can bring interdisciplinary, international teams together to improve our research and benefit patients. Teams at GOSH and UCL that specialise in organoid research in the UK, working with Italian teams specialising in design and application of gel-printing, are what have made this incredible and beautiful piece of research come to fruition. This will have implications for laboratory-based research to improve our understanding of disease but could also lead to in-patient uses and treatments.
Next steps for this work will be to study these controlled, moulded and directed mini-organs to better understand how they can mimic real organs and conditions in the body.
This work was funded by 2017 STARS-WiC grant of University of Padova, Progetti di Eccellenza CaRiPaRo, TWINING of University of Padova, Oak Foundation Award, AFM Telethon , ‘Consorzio per la Ricerca Sanitaria’ (CORIS) of the Veneto Region, Italy (LifeLab Program), European Research European Research Council (ERC, ReprOids) to N.E., and the STARS Starting Grant 2017 of University of Padova and IRP Consolidator Grant to A.U., NIHR GOSH Biomedical Research Centre and GOSH Children’s Charity
Reducing oxygen levels for children in intensive care will save lives
A new landmark study led from GOSH has found that reducing oxygen levels for critically ill children on mechanical ventilators in intensive care could save lives
GOSH to provide support for AI and Machine Learning as part of new paediatric HealthTech Research Centre
GOSH will support the new Child and Young People’s HealthTech Research Centre (HRC), led by Sheffield Children’s Hospital, as leads for AI and Machine Learning.
Clinical trial results give new hope for children with rare brain tumours
Researchers who are searching for better treatments for an incredibly rare type of brain tumour have published successful results from the latest rounds of clinical trials.
GOSH receives new MHRA authorisation to manufacture viral vectors
GOSH has been granted a Manufacturer's Authorisation Licence for the manufacture of viral vectors, which will accelerate Cell and gene therapies (CGT) clinical trials worldwide and expand the novel treatments that we can offer to our patients.